Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Trial date set for Boston Scientific executive’s accused killer
A Minnesota state court set a trial date for Lyle “Ty” Hoffman, who’s accused of killing Boston Scientific executive Kelly Phillips last August.
Hoffman and Phillips had a romantic relationship and were partners in a Minneapolis bar. But the relationship ended and Hoffman, who was managing the bar, was fired and evicted from Phillips’ home in Minneapolis, the Twin Cities Pioneer Press reported. Hoffman, charged with 1 count of intentional 2nd-degree murder, pleaded not guilty, the newspaper reported. Read more
2. Infraredx study: NIRS may help assess cardiac risk
Infraredx touted a study in the Journal of the American College of Cardiology showing its imaging technology could help cardiologists assess a patient’s risk for suffering a heart attack or stroke.
The study used Infraredx’s intravascular near-infrared spectroscopy technology to evaluate levels of lipid-core-containing plaque in the arteries of 203 patients who exhibited signs of reduced blood flow to the heart. Researchers focused on arteries that had not been directly implicated in the patient’s condition. Read more
1. Report: Lawyer says Guidant didn’t breach deal with J&J
A former outside lawyer who repped Guidant Corp. during the bidding war between Boston Scientific (and Johnson & Johnson reportedly told a judge yesterday that Guidant was within its rights to provide due diligence to Abbott in connection with the Boston Scientific bid.
Johnson & Johnson is suing Boston Scientific for $7.2 billion, alleging that Guidant breached their 21.5 billion acquisition contract in providing the information to Abbott. But Guidant’s ex-outside counsel, Charles Mulaney of Skadden Arps Slate Meagher & Flom, told Judge Richard Sullivan that Abbott was considered a “representative” of Boston Scientific under a confidentiality agreement, according to Law360. Read more
